Home » Stocks » NOVT

Novanta Inc. (NOVT)

Stock Price: $132.33 USD -1.50 (-1.12%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
After-hours: $133.00 +0.67 (0.51%) Feb 26, 7:54 PM
Market Cap 4.65B
Revenue (ttm) 602.83M
Net Income (ttm) 41.08M
Shares Out 35.14M
EPS (ttm) 1.15
PE Ratio 115.07
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $132.33
Previous Close $133.83
Change ($) -1.50
Change (%) -1.12%
Day's Open 134.38
Day's Range 131.99 - 136.78
Day's Volume 120,529
52-Week Range 66.44 - 146.16

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Benzinga - 2 days ago

Novanta (NASDAQ:NOVT) releases its next round of earnings this Monday, March 01. Here is Benzinga's essential guide to Novanta's Q4 earnings report.

Zacks Investment Research - 6 days ago

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 3 weeks ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth q...

Business Wire - 2 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matth...

Business Wire - 2 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robe...

Seeking Alpha - 3 months ago

Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Novanta (NOVT) delivered earnings and revenue surprises of 5.00% and 0.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 3 months ago

Shares of Novanta (NASDAQ:NOVT) rose 0.8% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 20.75% over the past year to $0.42, which ...

Business Wire - 3 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial ...

Zacks Investment Research - 3 months ago

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 4 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matt...

Business Wire - 4 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third qu...

Zacks Investment Research - 6 months ago

Top Ranked Momentum Stocks to Buy for August 28th

Other stocks mentioned: JYNT, LZB, MEDP
Business Wire - 6 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc.

Seeking Alpha - 6 months ago

Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 6 months ago

Novanta (NOVT) delivered earnings and revenue surprises of 100.00% and 4.78%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 6 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc.

Zacks Investment Research - 6 months ago

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 7 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second q...

Business Wire - 8 months ago

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (NASDAQ: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matt...

Seeking Alpha - 9 months ago

Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 9 months ago

Novanta (NOVT) delivered earnings and revenue surprises of 59.38% and 9.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 9 months ago

Shares of Novanta (NASDAQ:NOVT) were unchanged at $87.91 after the company reported Q1 results.

Zacks Investment Research - 9 months ago

Figuring out toxic stocks and abandoning them at the right time is the key to shield your portfolio from big losses.

Other stocks mentioned: ADNT, SINA, SITE, TTD
Zacks Investment Research - 10 months ago

Novanta Inc. (NOVT) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Seeking Alpha - 1 year ago

Novanta Inc. (NOVT) CEO Matthijs Glastra on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Novanta (NOVT) delivered earnings and revenue surprises of 1.85% and 1.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 1 year ago

Novanta, Inc.: A Better Odds-On Capital-Gain Alternative To Intuitive Surgical

The Motley Fool - 1 year ago

Here's your proof for taking a long-term approach to investing.

Other stocks mentioned: DPZ, EXAS, NBIX, NFLX
Seeking Alpha - 1 year ago

Novanta Inc. Buy-Ranked For Near Cap-Gains By Market-Makers

The Motley Fool - 1 year ago

One familiar name tops the list, but the others may surprise you.

Other stocks mentioned: AVGO, NFLX, OLED, TCX
Seeking Alpha - 1 year ago

Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Novanta (NOVT) delivered earnings and revenue surprises of 1.92% and -0.70%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Novanta (NOVT) delivered earnings and revenue surprises of 0.00% and 0.37%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GuruFocus - 1 year ago

CFO of Novanta Inc (NASDAQ:NOVT) Robert Buckley sold 16,277 shares of NOVT on 07/08/2019 at an average price of $91.06 a share.

Zacks Investment Research - 1 year ago

Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 year ago

Bright Near-Term Outlook for Electronics Components Industry

Other stocks mentioned: OLED, OSIS, ROG
Seeking Alpha - 1 year ago

Novanta, Inc. (NOVT) CEO Matthijs Glastra on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Novanta (NOVT) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research - 1 year ago

Novanta (NOVT) delivered earnings and revenue surprises of 8.16% and 0.58%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 1 year ago

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 1 year ago

Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 year ago

Novanta is well positioned to outperform the market, as it exhibits above-average growth in financials.

About NOVT

Novanta, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, an... [Read more...]

Industry
Scientific & Technical Instruments
Founded
1968
CEO
Matthijs Glastra
Employees
2,290
Stock Exchange
NASDAQ
Ticker Symbol
NOVT
Full Company Profile

Financial Performance

In 2019, Novanta's revenue was $626.10 million, an increase of 1.91% compared to the previous year's $614.34 million. Earnings were $40.77 million, a decrease of -16.97%.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Novanta stock is "Hold." The 12-month stock price forecast is 118.00, which is a decrease of -10.83% from the latest price.

Price Target
$118.00
(-10.83% downside)
Analyst Consensus: Hold